Remove tag investment-fund
article thumbnail

Grand Rounds Ethics and Regulatory Series September 9, 2022: Building An Academic Learning Health System: Why Is It So Hard? (Steven Joffe, MD, MPH)

Rethinking Clinical Trials

Dr. Joffe and his collaborators conducted a preliminary study of qualitative interviews, funded by PCORI, with 99 leaders of 16 geographically diverse Learning Health Systems. They place a high value on external funding that their faculty bring into the institution. There might be an opportunity to learn from the lessons of Covid.

article thumbnail

Brave Robot Launches Plant-Based, Climate-Friendly Cake Mix

XTalks

The release of the cake mix comes just weeks after Perfect Day secured another $350 million from a Series D funding round led by the Canada Pension Plan Investment Board and Temasek Holdings. The latest investment brings the company’s total funding amount to $711.5 percent from 2019 to 2025.

Protein 98
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Clover Biopharmaceuticals Announces Publication of Phase 1 Clinical Trial Data for its Adjuvanted COVID-19 Vaccine Candidates in The Lancet

The Pharma Data

The Coalition for Epidemic Preparedness Innovations (CEPI) has committed to fund Clover’s S-Trimer COVID-19 vaccine candidate through licensure with a total investment of up to $328 million , a portion of which will support the global Phase 2/3 study. About Trimer-Tag© Technology. —- End —-.

article thumbnail

Will Plant-Based Meat Prices Ever Be Lower Than Real Meat?

XTalks

But yet, the price tag is still higher than real meat. Most companies in the field have been largely funded by venture capital so far, which only magnifies these costs. A pound of Beyond Meat’s Beef burgers carries a price tag of $6.25, Vox reported. Turning a Profit. Wouldn’t the higher demand lower plant-based meat prices ?

Protein 105
article thumbnail

Deerfield/ Dana-Farber’s USD 130 Million Cancer Research Deal; FDA-Approval to BMS’ Breyanzi & TG Therapeutics’ Ukoniq; EU Marketing Rights for ViiV Healthcare’s Rukobia

Delveinsight

The move came not long after healthcare investor giant Deerfield Management has forged a partnership to create the Center for Protein Degradation, investing worth USD 80 million. For the same reason, Deerfield has decided to invest USD 130 Million over the next ten years at Dana-Farber.

article thumbnail

Oslo Medicines Initiative asks how to balance innovation incentivisation with security of access

pharmaphorum

And as with many healthcare challenges, it is an issue that has been brought into sharp focus by COVID-19, during which we have seen huge investments in ground-breaking vaccines, quickly followed by inequities in access. Flawed funding model.

article thumbnail

Clover and Dynavax Announce Planned Global Phase 2/3 Efficacy Trial of Adjuvanted COVID-19 Vaccine Candidate

The Pharma Data

The Coalition for Epidemic Preparedness Innovations (CEPI) continues to support Clover’s COVID-19 vaccine candidate and will fund its development through licensure. Utilizing Clover’s proprietary Trimer-Tag© technology, S-Trimer is a trimeric SARS-CoV-2 spike (S)-protein subunit vaccine candidate.